List of Figures
Number of Products under Development for Recurrent Malignant Glioma, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Top 10 Routes of Administration, H2 2019
Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Top 10 Molecule Types, H2 2019


List of Tables
Number of Products under Development for Recurrent Malignant Glioma, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Recurrent Malignant Glioma - Pipeline by Advenchen Laboratories LLC, H2 2019
Recurrent Malignant Glioma - Pipeline by Anew Oncology Inc, H2 2019
Recurrent Malignant Glioma - Pipeline by Candel Therapeutics, H2 2019
Recurrent Malignant Glioma - Pipeline by GtreeBNT Co Ltd, H2 2019
Recurrent Malignant Glioma - Pipeline by Hebei Senlang Biotechnology Inc Ltd, H2 2019
Recurrent Malignant Glioma - Pipeline by Immunomic Therapeutics Inc, H2 2019
Recurrent Malignant Glioma - Pipeline by InSight Biopharmaceuticals Ltd, H2 2019
Recurrent Malignant Glioma - Pipeline by PharmAbcine Inc, H2 2019
Recurrent Malignant Glioma - Pipeline by Stella Pharma, H2 2019
Recurrent Malignant Glioma - Dormant Projects, H2 2019
Recurrent Malignant Glioma - Dormant Projects, H2 2019 (Contd..1), H2 2019
Recurrent Malignant Glioma - Discontinued Products, H2 2019